THE ROLE OF REDUCTASES IN DRUG DISCOVERY AND DEVELOPMENT

被引:0
|
作者
Di, Li [1 ]
机构
[1] Pfizer Inc, New York, NY USA
关键词
D O I
10.1016/j.dmpk.2018.09.216
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P136
引用
收藏
页码:S62 / S62
页数:1
相关论文
共 50 条
  • [1] Role of drug metabolism in drug discovery and development
    Kumar, GN
    Surapaneni, S
    MEDICINAL RESEARCH REVIEWS, 2001, 21 (05) : 397 - 411
  • [2] Drug Discovery and Development: the Role of NMR
    Everett, Jeremy R.
    EMAGRES, 2015, 4 (01): : 137 - 149
  • [3] Role of pharmacogenomics in drug discovery and development
    Surendiran, A.
    Pradhan, S. C.
    Adithan, C.
    INDIAN JOURNAL OF PHARMACOLOGY, 2008, 40 (04) : 137 - 143
  • [4] The role of academia in drug discovery and development
    Yamada, Yasuhide
    Kim, Tae Won
    CANCER SCIENCE, 2018, 109 : 42 - 42
  • [5] The Role of Radiopharmaceuticals in Drug Discovery and Development
    Kairemo, Kalevi
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (09) : 926 - 927
  • [6] Role of toxicology in drug discovery and development
    Goldstein, RS
    IDEA TO PRODUCT: THE PROCESS, 1996, : 47 - 48
  • [7] The evolving role of drug metabolism in drug discovery and development
    Yengi, Lilian G.
    Leung, Louis
    Kao, John
    PHARMACEUTICAL RESEARCH, 2007, 24 (05) : 842 - 858
  • [8] The Evolving Role of Drug Metabolism in Drug Discovery and Development
    Lilian G. Yengi
    Louis Leung
    John Kao
    Pharmaceutical Research, 2007, 24
  • [9] A REVIEW ON THE ROLE OF PHARMACOGENOMICS IN DRUG DISCOVERY AND DEVELOPMENT
    Ojha, Anup
    Joshi, Tanuj
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2016, 7 (09): : 3587 - 3595
  • [10] Role of pharmacokinetics and metabolism in drug discovery and development
    Lin, JH
    Lu, AYH
    PHARMACOLOGICAL REVIEWS, 1997, 49 (04) : 403 - 449